Contineum Therapeutics (CTNM) Other Working Capital Changes (2023 - 2026)
Contineum Therapeutics' (CTNM) quarterly Other Working Capital Changes came in at -$1.3 million in Q1 2026, down 404.28% year-on-year from $425923.3 in Q1 2025, and down 161.82% quarter-over-quarter from -$495000.0 in Q4 2025.
Contineum Therapeutics (CTNM) Other Working Capital Changes (2023 - 2026) Analysis & Trends
Contineum Therapeutics' Other Working Capital Changes history runs 4 years deep, the most recent figure standing at -$1.3 million for Q1 2026.
- On a quarterly basis, Other Working Capital Changes fell 404.28% year-over-year to -$1.3 million in Q1 2026; TTM through Mar 2026 was -$2.3 million, a 1033.0% decrease from a year earlier, with the FY2025 full-year figure at -$1.3 million, down 2010.61% from the prior year.
- Other Working Capital Changes slipped to -$1.3 million in Q1 2026 per CTNM's latest filing, from -$495000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $2.5 million in Q4 2025 and bottomed at -$713000.0 in Q1 2024.
- The 4-year median for Other Working Capital Changes is $24000.0 (2023), against an average of $415538.5.
- Across the five-year window, Other Working Capital Changes jumped 105.12% in 2024 and tumbled 2241.67% in 2025, its largest moves.
- Year by year, Other Working Capital Changes stood at -$549000.0 in 2023, then surged by 105.1% to $28000.0 in 2024, then slumped by 1867.86% to -$495000.0 in 2025, then tumbled by 161.82% to -$1.3 million in 2026.
- Per Business Quant, the three latest CTNM Other Working Capital Changes figures stand at -$1.3 million (Q1 2026), -$495000.0 (Q4 2025), and -$257000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Contineum Therapeutics | 536.56 Mn | 536.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.30 Mn |
| Mar 31, 2026 | -1.30 Mn |
| Mar 31, 2026 | -1.30 Mn |
| Dec 31, 2025 | -495,000.00 |
| Dec 31, 2025 | -495,000.00 |
| Dec 31, 2025 | -495,000.00 |
| Sep 30, 2025 | -257,000.00 |
| Sep 30, 2025 | -257,000.00 |
| Sep 30, 2025 | -257,000.00 |
| Jun 30, 2025 | -252,000.00 |
| Jun 30, 2025 | -252,000.00 |
| Jun 30, 2025 | -252,000.00 |
| Mar 31, 2025 | -257,000.00 |
| Mar 31, 2025 | -257,000.00 |
| Mar 31, 2025 | -257,000.00 |
| Dec 31, 2024 | 28,000.00 |
| Dec 31, 2024 | 28,000.00 |
| Dec 31, 2024 | 28,000.00 |
| Sep 30, 2024 | 13,000.00 |
| Sep 30, 2024 | 13,000.00 |